EKLDC:PA:PA-BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation (EUR)

ETF | Others |

Last Closing

USD 19.5898

Change

0.00 (0.00)%

Market Cap

N/A

Volume

804.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.02 (-0.05%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-17.40 (-3.70%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-10.14 (-3.00%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.97 (-3.16%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-12.31 (-5.27%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-10.20 (-2.57%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-9.15 (-3.01%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-1.80 (-3.77%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.32 (-5.25%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-2.36 (-3.16%)

USD 5.54B

ETFs Containing EKLDC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.92% 16% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.92% 16% F 21% F
Trailing 12 Months  
Capital Gain -5.32% 24% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.32% 23% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.00% 59% D- 65% D
Dividend Return 10.00% 58% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.10% 63% D 43% F
Risk Adjusted Return 99.07% 76% C+ 45% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike